Trijugin-type limonoids from the leaves of Cipadessa cinerascens

Journal of Natural Products

Volumn 70, Issue 8, 2007, Pages 1352-1355

  Di, Ying Tong ^a,b   He, Hong Ping ^a   Liu, Hai Yang ^a   Yi, Ping ^a   Zhang, Zhen ^c   Ren, Yan Li ^d   Wang, Jun Song ^a   Sun, Qian Yun ^e   Yang, Fu Mei ^e   Fang, Xin ^a   Li, Shun Lin ^a   Zhu, Hua Jie ^a   Hao, Xiao Jiang ^a  

^a KUNMING INSTITUTE OF BOTANY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c DALI UNIVERSITY   (China)

^d HUNAN AGRICULTURAL UNIVERSITY   (China)

^e INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CIPADESIN A; CIPATRIJUGIN A; CIPATRIJUGIN B; CIPATRIJUGIN C; CIPATRIJUGIN D; LIMONOID; PLANT EXTRACT; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CIPADESSA CINERASCENS; DRUG ISOLATION; DRUG STRUCTURE; HUMAN; HUMAN CELL; MATHEMATICAL COMPUTING; MEDICINAL PLANT; PLANT LEAF; SPECTROSCOPY; STRUCTURE ANALYSIS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG SCREENING ASSAYS, ANTITUMOR; DRUGS, CHINESE HERBAL; HUMANS; LIMONINS; MELIACEAE; MOLECULAR STRUCTURE; PLANT LEAVES; PLANTS, MEDICINAL;

CIPADESSA;

EID: 34548642382     PISSN: 01633864     EISSN: None     Source Type: Journal    
DOI: 10.1021/np0700624     Document Type: Article

References (28)

1. (a) Champagne, D. E.; Koul, O.; Isman, M. B.; Scudder, G. G. E.; Towers, G. H. N. Phytochemistry 1992, 31, 377-394.
2. (b) Akhila, A.; Rani, K. In Progress in the Chemistry of Natural Products; Herz, W., Falk, H., Kirby, G. W., Moore, R. E., Eds.; Springer: Vienna, 1999; Vol. 78, pp 47-149.
3. (c) Mulholland, D. A.; Coombers, P. H. Curr. Org. Chem. 2004, 4, 1011-1054.
4. (d) Roy, A.; Saraf, S. Biol. Pharm. Bull. 2006, 29, 191-201.
5. (a) Mitsui, K.; Saito, H.; Yamamura, R.; Fukaya, H.; Hitotsuyanagi, Y.; Takeya, K. J. Nat. Prod. 2006, 69, 1310-1314.
6. (b) Saewan, N.; Sutherland, J. D.; Chantrapromma, K. Phytochemistry 2006, 67, 2288-2293.
7. (c) Wang, X.-N.; Yin, S.; Fan, C.-Q.; Wang, F.-D.; Lin, L.-P.; Ding, J.; Yue, J.-M. Org. Lett. 2006, 8, 3845-3848.
8. (d) Yin, S.; Fan, C.-Q.; Wang, X.-N.; Lin, L.-P.; Ding, J.; Yue, J.-M. Org. Lett. 2006, 8, 4935-4938.
9. (e) Hay, A.-E.; Ioset, J.-R.; Ahua, K. M.; Diallo, D.; Brun, R.; Hostettmann, K. J. Nat. Prod. 2007, 70, 9-13.
10. (f) Chen, J. L.; Kernan, M. R.; Jolad, S. D.; Stoddart, C. A.; Bogan, M.; Cooper, R. J. Nat. Prod. 2007, 70, 312-315.
11. Editorial Committee (over 300 members) of the Administration Bureau of Traditional Chinese Medicine. In Chinese Materia Medica (Zhonghua Benchao); Shanghai Science & Technology Press: Shanghai, 1998; Vol. 5, pp 32-33.
12. (a) Luo, X.-D.; Wu, S.-H.; Ma, Y.-B.; Wu, D.-G. Phytochemistry 2000, 55, 867-872.
13. (b) Yuan, X.-H.; Li, B.-G.; Zhou, M.; Qi, H.-Y.; Zhang G.-L. Org. Lett. 2005, 7, 5051-5053.
14. (c) Ren, Y. -L.; Tang, Q.-R.; Di, Y.-T.; He, H.-P.; Zhang, Z.; Li, S.-L.; Hao, X. J. Helv. Chim. Acta 2007, 90, 764-768.
15. (a) Liang, L.; Zhong, C.-C.; Xiao, Z.-Y. Zhongcaoyao 1990, 21, 2-4.
16. (b) Liang, L.; Zhong, C.-C.; Xiao, Z.-Y. Zhongcaoyao 1991, 22, 6-8.
17. (c) Rojatkar, S. R.; Nagasampagi, B. A. Phytochemistry 1994, 37, 505-507.
18. (d) Rojatkar, S. R.; Chiplunkar, Y. G.; Nagasampagi, B. A. Phytochemistry 1994, 37, 1213-1214.
19. (e) Liang, L.; Zhong, C.-C.; Xiao, Z.-Y. Zhongcaoyao 1994, 25, 236-237.
20. (a) Purushothaman, K. K.; Venkatanarasimhan, M.; Sarada, A. L.; Connolly, J. D.; Rycroft, D. D. Can. J. Chem. 1987, 65, 35-37.
21. (b) Kehrli, A. R. H.; Taylor, D. A. H.; Miven, M. Phytochemistry 1990, 29, 153-159.
22. (c) Mulholland, D. A.; Lourine, S. E. Phytochemistry 1998, 47, 1357-1361.
23. (d) Ismail, I. S.; Ito, H.; Hatano, T.; Taniguchi, S.; Yoshida, T. Phytochemistry 2003, 64, 1345-1349.
24. (e) Zhang, H.-P.; Wu, S.-H.; Shen, Y.-M.; Ma, Y.-B.; Wu, D.-G.; Qi, S.-H.; Luo, X.-D. Can. J. Chem. 2003, 81, 253-257.
25. (f) Ismail, I. S.; Ito, H.; Hatano, T.; Taniguchi, S.; Yoshida, T. Chem. Pharm. Bull. 2004, 52, 1145-1147.
26. Gaussian 03, revision B.04; Gaussian, Inc.: Pittsburgh, PA, 2003.
27. The relative configuration of 4 was also analyzed by molecular models, energy minimized using density functional theory (DFT) at the 3-21G* basis set level in Gaussian 03, which overlaid with key correlations observed in the ROESY NMR spectrum. For details see the Supporting Information.
28. Mosmann, T. J. Immunol. Methods 1983, 65, 55-63.